A multi-faceted approach of one teaching hospital nhs trust during the clostridium difficile epidemic—antibiotic management and beyond

Antibiotics

Volumn 5, Issue 1, 2016, Pages

  White, Helena ^a   Wiselka, Martin ^a   Bell, David ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Antimicrobial stewardship; Care bundle approach; Clostridium difficile associated disease; Clostridium difficile infection

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; CIPROFLOXACIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; EDUCATION; HEALTH CARE PLANNING; HOSPITAL HYGIENE; HOSPITAL MANAGEMENT; HUMAN; MEDICAL STAFF; PATIENT CARE; PRESCRIPTION; PRIORITY JOURNAL; TEACHING HOSPITAL; WARD;

EID: 85019779821     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics5010013     Document Type: Article

References (21)

1. Dubberke, E.R.; Olsen, M.A. Burden of Clostridium difficile on the Healthcare System. Clin. Infect. Dis. 2012, 55, S88-S92. [CrossRef] [PubMed]
2. Loo, V.G.; Poirier, L.; Miller, M.A.; Oughton, M.; Libman, M.D.; Michaud, S.; Bourgault, A.M.; Nguyen, T.; Frenette, C.; Kelly, M., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficileassociated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005, 353, 2442-2449. [CrossRef] [PubMed]
3. Department of Health and Health Protection Agency. Clostridium Difficile Infection: How to Deal with the Problem; Department of Health: London, UK, 2008
4. Muto, C.A.; Pokrywka, M.; Shutt, K.; Mendelsohn, A.B.; Nouri, K.; Posey, K.; Roberts, T.; Croyle, K.; Krystofiak, S.; Patel-Brown, S. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect. Control Hosp. Epidemiol. 2005, 26, 273-280. [CrossRef] [PubMed]
5. McDonald, L.C.; Killgore, G.E.; Thompson, A.; Owens, R.C., Jr.; Kazakova, S.V.; Sambol, S.P.; Johnson, S.; Gerding, D.N. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 2005, 353, 2433-2441. [CrossRef] [PubMed]
6. Warny, M.; Pepin, J.; Fang, A.; Killgore, G.; Thompson, A.; Brazier, J.; Frost, E.; McDonald, L.C. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366, 1079-1084. [CrossRef]
7. Kuijper, E.; Barbut, F.; Brazier, J.; Kleinkauf, N.; Eckmanns, T.; Lambert, M. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Eurosurveillance 2008, 13, 433-439
8. Chief Medical Officer. Infection caused by Clostridium difficile; Letter to Health Professionals. 2005. Available Online: http://webarchive.nationalarchives.gov.uk/20120405095111/http://www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Professionalletters/Chiefmedicalofficerletters/DH_4125069 (accessed on 27 November 2015).
9. Public Health England. Clostridium difficile Infection: Criteria for Reporting. 2014. Available Online: https://www.gov.uk/government/publications/clostridium-difficile-infection-criteria-for-reporting (accessed on 1 June 2015).
10. Leicestershire Medicines Strategy Group. Guidelines for the Prescribing of Proton Pump Inhibitors (PPI) in Adults. 2015. Available Online: http://www.lmsg.nhs.uk/wp-content/uploads/2015/06/ PPIguidelinesMarch-2015-.pdf (accessed on 27 November 2015).
11. Leicester and Leicestershire Commnunity Partnership NHS Trusts. News Release—Stop! Clean Your Hands! 2007. Available online: http://www.lcr.nhs.uk/Library/010%20stop%20-%20clean%20your%20hands.pdf (accessed on 20 October 2015).
12. National Institute for Health and Care Excellence. Healthcare-Associated Infections: Prevention and Control in Primary and Community Care; NICE: London, UK, 2012
13. Department of Health. Clean, Safe Care: Reducing Infections and Saving Lives; Department of Health: London, UK, 2008
14. Hussain, A.; Jenkins, D.; Parsons, K.; Alleyne, S. Antibiotic Quantitative (QUAN) and Qualitative (QUAL) Policies: Differential Effects on Clostridium difficile-Associated Diarrhoea (CDAD). In Proceedings of Infectious Diseases Society of America Annual Meeting; Infectious Diseases Society of America: Washington, DC, USA, 2008
15. Muto, C.A.; Blank, M.K.; Marsh, J.W.; Vergis, E.N.; O’Leary, M.M.; Shutt, K.A.; Pasculle, A.W.; Pokrywka, M.; Garcia, J.G.; Posey, K. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin. Infect. Dis. 2007, 45, 1266-1273. [CrossRef] [PubMed]
16. Linsky, A.; Gupta, K.; Lawler, E. Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile infection. Arch. Intern. Med. 2010, 170, 772-778. [CrossRef] [PubMed]
17. Dial, S.; Delaney, J.A.; Barkun, A.N. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005, 294, 2989-2995. [CrossRef] [PubMed]
18. Abbett, S.K.; Yokoe, D.S.; Lipsitz, S.R. Proposed Checklist of Hospital Interventions to Decrease the Incidence of Healthcare-Associated Clostridium difficile Infection. Infect. Control Hosp. Epidemiol. 2009, 30, 1062-1069. [CrossRef] [PubMed]
19. Public Health England. Clostridium difficile: Guidance, Data and Analysis. 2015. Available Online: https://www.gov.uk/government/collections/clostridium-difficile-guidance-data-and-analysis (accessed on 1 June 2015).
20. Saint, S.S.; Kowalski, C.P.; Banaszak-Holl, J. The Importance of Leadership in Preventing Healthcare-Associated Infection: Results of a Multisite Qualitative Study. Infect. Control Hosp. Epidemiol. 2010, 31, 901-907. [CrossRef] [PubMed]
21. National Institute for Health and Care Excellence. Healthcare-Associated Infections: Prevention and Control; NICE: London, UK, 2011.